MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹527 Cr | ₹477 Cr | ₹390 Cr | ₹341 Cr | ₹380 Cr |
What is the latest Total Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹527 Cr |
| Mar2025 | ₹477 Cr |
| Mar2024 | ₹390 Cr |
| Mar2023 | ₹341 Cr |
| Mar2022 | ₹380 Cr |
How is Total Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹527 Cr | 10.42 | |
| Mar2025 | ₹477 Cr | 22.44 | |
| Mar2024 | ₹390 Cr | 14.33 | |
| Mar2023 | ₹341 Cr | -10.29 | |
| Mar2022 | ₹380 Cr | - | |
Compare Total Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹12,408.6 Cr | 4.4% | -1.1% | 18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 4.4% |
-1.1% |
18.1% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses